Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...
Measles outbreaks in West Texas and New Mexico now have more than 250 cases total. Two unvaccinated people have died from ...
Vaccine research has increasingly focused on virus-like particles (VLPs) due to their unique ability to mimic the structures of viruses without containing ...
Norovirus is also hard to kill on surfaces, where it can live for days to weeks. If someone in your household vomits in the ...
11d
Pharmaceutical Technology on MSNEC approves Bavarian Nordic’s chikungunya vaccine marketingThe European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine ...
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...
Measles virus particle, illustration. (Photo by KATERYNA KON/SCIENCE PHOTO ... meaning it was without continuous spread for at least 12 months. MMR vaccine is like a shield The CDC currently ...
There’s been increasing anxiety over the last several weeks about an outbreak of measles in Texas and New Mexico. Public health officials in the Southwest are sounding the alarm — including Will ...
Additionally, the HKU5-CoV-2 does not enter human cells like the SARS-CoV-2 virus that causes Covid-19. While there are numerous coronaviruses out there, only a few can infect humans. Disclaimer ...
that compared the safety and immunogenicity of a single intramuscular dose of Vimkunya (n=2559), a virus-like particle chikungunya vaccine, with placebo (n=424) in healthy participants 12 to 64 years ...
For the new study, Parrish and his team cloned the antibodies and used cryo-electron microscopy to determine their structures and interaction with the virus particle, showing where on the surface ...
COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has approved VIMKUNYA™ (Chikungunya Vaccine, Recombinant) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results